Australia's Immunisation Foundation has uncovered a concerning issue in the fight against whooping cough, a disease that has been ravaging the country at alarming rates. Despite the severity of the outbreak, many hospitals are failing to take advantage of a simple yet effective solution: incorporating a whooping cough booster into routine tetanus vaccinations.
The foundation's investigation revealed that only a minority of hospitals are stocking the combined vaccine, which provides protection against both tetanus and whooping cough. This is despite health guidelines strongly recommending its use in emergency departments for wound management. Studies indicate that current immunisation levels are alarmingly low, which is a critical concern given the disease's high contagiousness and potential for severe complications, especially in infants and young children.
Whooping cough, also known as the '100-day cough', is a bacterial infection that can be life-threatening for babies and young children. The outbreak has seen a staggering 80,000 cases reported in the past two years, a record high. The infection causes uncontrollable coughing and breathing difficulties, making it more contagious than the flu or COVID-19.
Catherine Hughes, the founder of the Immunisation Foundation, expressed her dismay at the situation. She highlighted the irony of hospitals using vaccines for tetanus, a disease that can be prevented by the combined jab, without including the crucial whooping cough component. Ms. Hughes' personal tragedy, the loss of her son Riley to whooping cough at just 32 days old, adds a deeply emotional layer to her advocacy.
The investigation further revealed that a significant number of hospitals are still using the older diphtheria and tetanus vaccine, which does not offer protection against whooping cough. This has led to the administration of the older vaccine to one million adults over 50, who were seeking tetanus protection. The cost of the combined vaccine is a minor additional expense, yet it could significantly improve immunisation rates.
Raina MacIntyre, a leading expert in global biosecurity, emphasised the importance of adult vaccination in managing the outbreak. She noted that adults play a significant role in the spread of whooping cough, making their vaccination a crucial part of the solution. The disease's impact on adults, while less severe than in infants, can still lead to serious complications.
This issue highlights a critical gap in Australia's healthcare system, where a simple, cost-effective solution is being overlooked. The Immunisation Foundation's findings underscore the need for stricter adherence to health guidelines and a more comprehensive approach to immunisation, especially in the face of an unprecedented whooping cough outbreak.
